DYNC1H1 - Charcot-Marie-Tooth disease type 20

This test is available for the following conditions:

  • Conditions > Neurological > Charcot-Marie-Tooth disease

This product is also part of the following panels:

  • Epilepsy panel
  • Intellectual disability panel with genome wide CNV analysis
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • Muscle disorders panel
  • Neurological pain disorders panel¹
  • Neuropathies panel¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 600112
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 740

Gene

DYNC1H1 - Charcot-Marie-Tooth disease type 20

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 740

DYNC1H1 - Charcot-Marie-Tooth disease type 20



€ 740
Gene

INF2 - dominant intermediate Charcot-Marie-Tooth disease

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 468

INF2 - dominant intermediate Charcot-Marie-Tooth disease



€ 468

INF2 - dominant intermediate Charcot-Marie-Tooth disease

This test is available for the following conditions:

  • Conditions > Neurological > Charcot-Marie-Tooth disease

This product is also part of the following panels:

  • Mendelian inherited disorders panel with genome wide CNV analysis
  • Neuropathies panel¹
  • Renal disorders panel

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 610982
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 468